Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

predictive

  • You have access
    Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy
    MARTIN SVATON, JIRI BLAZEK, GABRIELA KRAKOROVA, MILOS PESEK, MARCELA BURESOVA, ZUZANA TEUFELOVA, JOSEF VODICKA, KAROLINA HURDALKOVA, MAGDA BARINOVA and ONDREJ TOPOLCAN
    Anticancer Research April 2021, 41 (4) 2053-2058; DOI: https://doi.org/10.21873/anticanres.14974
  • You have access
    Timing of Severe Toxicity from Chemotherapy in Patients With Lung Cancer
    KRISTINA SJØGREN, KRISTIAN AALBERG JACOBSEN, BJØRN HENNING GRØNBERG and TARJE O. HALVORSEN
    Anticancer Research November 2020, 40 (11) 6399-6406; DOI: https://doi.org/10.21873/anticanres.14661
  • You have access
    COX2/PTGS2 Expression Is Predictive of Response to Neoadjuvant Celecoxib in HER2-negative Breast Cancer Patients
    PATRICIA DE CREMOUX, ANNE-SOPHIE HAMY, JACQUELINE LEHMANN-CHE, VÉRONIQUE SCOTT, BRIGITTE SIGAL, MARIE-CHRISTINE MATHIEU, PHILIPPE BERTHEAU, JEAN MARC GUINEBRETIÈRE, JEAN YVES PIERGA, SYLVIE GIACCHETTI, ETIENNE BRAIN, MICHEL MARTY, BERNARD ASSELAIN, FRÉDÉRIQUE SPYRATOS and IVAN BIÈCHE
    Anticancer Research March 2018, 38 (3) 1485-1490;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire